Manufacturer's investigation conclusion: eurosets confirmed a blood leak of the returned eurosets amg (advanced membrane gas exchange) pmp (polymethylpentene) oxygenator.A specific root cause for the leak could not be conclusively determined; however, fiber breakage was suspected.The eurosets amg standalone pmp infant oxygenator, lot # 8120500, was returned to abbott and an initial visual inspection was performed that confirmed blood residue in the gas inlet port and bottom and top housings.Visual inspection of the pmp fibers from the side of the oxygenator revealed no obvious damage and was unable to confirm fiber breakages.There were no other findings noted.The oxygenator was forwarded to the external manufacturer (eurosets) for technical analysis.The oxygenator was set up in a circuit with a 500-milliliter reservoir of physiological water and peristaltic pump.The water was circulated through the oxygenator for 10 minutes at a flow of 6 liters per minute.During this time, no leaking of any kind was observed to come from the oxygenator, most probably due the condition of the device at its arrival.Despite that, there were some traces of blood in the lower lid of the oxygenator and for this reason it was removed.The point of loss was not detectable, but the presence of blood can suggest a blood leakage due a broken fiber.The device history record for amg standalone pmp infant oxygenator, lot # 8120500, was reviewed by eurosets and showed that all tests from the production process were compliant with the technical specifications.Devices are required to pass manufacturing inspections and specifications prior to release and no abnormalities were documented which would cause or contribute to the reported occurrence.This device passed all required testing.Eurosets confirmed that 100% of the oxygenators produced are tested to detect eventual leakages using a pressure of 150 kpa (kilopascals) which is 1.5 times the maximum blood pathway pressure indicated on the ifu (instructions for use).The specific root cause of the reported issue could not be conclusively determined; however, eurosets determined that the issue occurred after eurosets manufacturing and test phases.Eurosets reported that after thoughtful and deep investigation on possible improvement processes, a series of additional, specific controls and manufacturing changes have been implemented which have been able to reduce the occurrence of this issue.The eurosets amg pmp instructions for use (ifu) warns that that during extracorporeal circulation (ecc) a backup oxygenator is necessary and also warns that the extracorporeal circulation has to be carefully and continuously checked.Before using the product, it is advisable to fully inspect it as shipping and handling could cause structural and functional damage to the device.The ifu also states that if particular situations occur which may lead the person responsible for perfusion to determine the safety of the patient may be compromised (insufficient oxygenator performance, leaks, abnormal blood parameters, etc.), follow the procedure outlined in the ifu for oxygenator replacement.The production documentation for amg standalone pmp infant oxygenator, lot # 8120500, was reviewed by the external manufacturer (eurosets) and showed that all tests made in the production process were compliant with the technical specifications.Devices are required to pass manufacturing inspections and specifications prior to release and no abnormalities were documented which would cause or contribute to the reported occurrence.This device passed all required testing.The eurosets amg pmp instructions for use (ifu) is currently available.Under the list of warnings, the ifu warns that during the extracorporeal circulation (ecc) a backup oxygenator is necessary and also warns that the extracorporeal circulation has to be carefully and continuously checked.Also, under the list of warnings, the ifu warns that ¿before using the product it is advisable to carefully inspect it.Shipping and handling could cause structural and functional damage to the device.¿ under the section titled ¿oxygenator replacement¿, this document states that a spare oxygenator must always be available during perfusion.After 6 hours of use with blood or if particular situations occur, which may lead the person responsible for perfusion to determine the safety of the patient may be compromised (insufficient oxygenator performance, leaks, abnormal blood parameters, etc.), follow the procedure outlined in the ifu for oxygenator replacement.No further information was provided.The manufacturer is closing the file on this event.
|